A2 BIO Logo (WIPO, 04/06/2022)
WIPOProtect this trademark from copycats!
With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.
The International trademark A2 BIO was filed as Figurative mark on 04/06/2022 at the World Intellectual Property Organization.
Logodesign (Wiener Klassifikation)
#Quadrilaterals #Letters presenting a special form of writing #Numerals presenting a special form of writing #Other irregular parallelograms, trapezia and quadrilaterals, quadrilaterals containing one or more rounded corners #Quadrilaterals containing one or more numerals #Quadrilaterals containing one or more letters #Quadrilaterals with dark surfaces or parts of surfaces
| Trademark form | Figurative mark |
| File reference | 1687385 |
| Countries | 
|
| Base trademark |
No. 97074028,
October 14, 2021
|
| Application date | April 6, 2022 |
| Expiration date | April 6, 2032 |
Trademark owner
30301 Agoura Road, Suite 210
Agoura Hills CA 91301
US
Agoura Hills CA 91301
US
Trademark representatives
411 Borel Avenue, Suite 603
San Mateo CA 94402
US
goods and services
05
Therapeutics in the nature of cells, proteins and protein
complexes for the treatment and prevention of cancer,
inflammation, and inflammatory diseases; biotherapeutics for
the treatment and prevention of cancer, inflammation, and
inflammatory diseases; medicines; pharmaceuticals;
pharmaceutical products for the treatment and prevention of
cancer and inflammatory diseases; therapeutic targets,
namely, cells, proteins and protein complexes, for the
treatment and prevention of cancer, inflammation and
inflammatory diseases; therapeutic cells, therapeutic
proteins and therapeutic antibodies for human use for the
treatment and prevention of cancer, inflammation and
inflammatory diseases; therapeutics and cell therapies in
the nature of cells, proteins and protein complexes for the
treatment of cancer, inflammation, and inflammatory
diseases; engineered cell therapies in the nature of cells,
proteins and protein complexes for medical purposes, namely,
the treatment and prevention of cancer, inflammation and
inflammatory diseases; engineered cell therapy platforms;
cell platforms for the treatment and prevention of cancer,
inflammation and inflammatory diseases; technology platforms
for developing and engineering therapeutic cells,
therapeutic proteins, therapeutic antibodies, therapeutics
and cellular therapies for the treatment and prevention of
cancer, inflammation, and inflammatory diseases; platform
for autologous and allogeneic cell manufacturing;
therapeutics and cell therapies in the nature of cells,
proteins and protein complexes targeting targets lost in
tumors for the treatment and prevention of cancer,
inflammation and inflammatory diseases; gene therapy
products, namely, genetically engineered tissues for
transplant purposes
40
Custom manufacturing of therapeutics, biotherapeutics,
medicines, and pharmaceuticals; manufacturing of cells,
therapeutics and cell therapies for the treatment and
prevention of cancer, inflammation and inflammatory
diseases; biomanufacturing for others; cell therapy
manufacturing for others; autologous and allogeneic cell
manufacturing for others; manufacturing services for others
in the fields of therapeutics, cell therapies, biologics,
medicine, and pharmaceuticals; providing technical
information in the field of pharmaceutical manufacturing;
custom manufacturing and engineering of biological cells,
cellular targets, proteins, and antibodies for others
42
Medical research services; pharmaceutical and
biopharmaceutical research and development services;
provision of information in the fields of therapeutics,
biotherapeutics, medicines, pharmaceuticals; provision of,
and identification and development of, therapeutic targets
for others for the treatment and prevention of cancer,
inflammation and inflammatory diseases; development of
therapeutics and cell therapies for treatment and prevention
of cancer, inflammation, and inflammatory diseases;
therapeutics and cell therapies targeting targets lost in
tumors for the treatment and prevention of cancer,
inflammation and inflammatory diseases; biotechnology
research, development, testing and analysis for the
treatment of cancer, inflammation, and inflammatory
diseases; scientific research and development services;
providing information relating to treatment and prevention
of cancer, inflammation and inflammatory diseases; research,
development, engineering and testing services in the fields
of therapeutics, cell therapies, biologics, medicine, and
pharmaceuticals; medical laboratory services, namely, tissue
material processing and analysis in the field of autologous
and allogeneic biologic preparations for medical use;
biotechnology laboratory services; scientific and medical
laboratory services; genetic engineering services
Trademark history
| Date | Document number | Area | Entry |
|---|---|---|---|
| August 3, 2023 | 2023/31 Gaz | JP | Rejection |
| March 7, 2023 | 2023/12 Gaz | CN | Rejection |
| February 28, 2023 | 2023/9 Gaz | EM | Rejection |
| December 28, 2022 | 2022/52 Gaz | GB | Rejection |
| April 6, 2022 | 2022/38 Gaz | US | Registration |
ID: 141687385